Thu, January 5, 2023

Edward Tenthoff Maintained (SYRS) at Buy with Decreased Target to $20 on, Jan 5th, 2023

Edward Tenthoff of Piper Sandler, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Decreased Target from $27 to $20 on, Jan 5th, 2023.

Edward has made no other calls on SYRS in the last 4 months.



There are 3 other peers that have a rating on SYRS. Out of the 3 peers that are also analyzing SYRS, 0 agree with Edward's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Edward


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Tuesday, November 15th, 2022
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $16 on, Tuesday, November 15th, 2022
  • Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $15 on, Tuesday, November 15th, 2022